• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today

FDA

Magnifying glass with pills on blue
Pharma

Regulatory tracker: Akeso's ivonescimab wins key nod in China

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu , Kevin Dunleavy , Fraiser Kansteiner Aug 12, 2026 9:13am
drug recall FDA recall recall voluntary recall

Fresenius Kabi recalls morphine lot that could lead to death

Aug 7, 2026 9:30am
FDA

UPDATE: Replimune secures FDA approval after long regulatory battle

Aug 6, 2026 4:41pm
Jazz and PharmaMar Zepzelca for small cell lung cancer

Jazz to withdraw Zepzelca in second-line small cell lung cancer

Aug 4, 2026 9:18am
NVS

Novartis' Pluvicto unlocks substantial new patient pool

Aug 3, 2026 8:33am
Karyopharm

Karyopharm reports Xpovio miss, FDA filing in separate cancers

Jul 31, 2026 10:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings